NasdaqGS:TXGLife Sciences
Is It Too Late To Consider 10x Genomics (TXG) After Its 185% One-Year Surge?
Investors may be wondering whether 10x Genomics is starting to look attractively priced after a volatile few years, or if the recent excitement has already been baked into the share price.
The stock last closed at US$23.58, with returns of 7.7% over 7 days, 25.5% over 30 days, 41.9% year to date and 185.0% over the past year, set against longer term returns of 56.1% over 3 years and 87.4% over 5 years.
These moves have put 10x Genomics firmly back on many investors' watchlists, especially as...